Hoya Co. (OTCMKTS:HOCPY) – Stock analysts at Jefferies Group reduced their Q4 2018 EPS estimates for Hoya in a research report issued on Wednesday, April 18th. Jefferies Group analyst M. Nakanomyo now forecasts that the technology company will post earnings per share of $0.57 for the quarter, down from their previous forecast of $0.59. Jefferies Group also issued estimates for Hoya’s FY2019 earnings at $2.82 EPS and FY2020 earnings at $2.96 EPS.

Hoya (OTCMKTS:HOCPY) last released its quarterly earnings data on Tuesday, January 30th. The technology company reported $0.64 earnings per share for the quarter, beating analysts’ consensus estimates of $0.62 by $0.02. The firm had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.23 billion. Hoya had a return on equity of 18.47% and a net margin of 18.84%.

Separately, Zacks Investment Research downgraded Hoya from a “buy” rating to a “hold” rating in a report on Tuesday, January 9th.

OTCMKTS:HOCPY opened at $55.26 on Thursday. The company has a market cap of $20,418.29, a PE ratio of 23.27, a P/E/G ratio of 2.02 and a beta of 0.85. Hoya has a fifty-two week low of $46.18 and a fifty-two week high of $58.24.

TRADEMARK VIOLATION WARNING: This piece of content was first reported by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of United States & international copyright and trademark law. The correct version of this piece of content can be read at https://www.watchlistnews.com/brokers-issue-forecasts-for-hoya-co-s-q4-2018-earnings-hocpy/2038209.html.

About Hoya

HOYA CORPORATION manufactures and sells precision devices and instruments based on advanced optics technologies in the fields of life care and information technology. It operates in two segments, Life Care and Information Technology. The company offers healthcare products, including eyeglass and contact lenses; and medical products, such as medical endoscopes, laparoscopic surgical instruments, intraocular lenses, prosthetic ceramic fillers and orthopedic implants, and airway scopes.

Receive News & Ratings for Hoya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hoya and related companies with MarketBeat.com's FREE daily email newsletter.